This book is a selective, revised and annotated compendium of the best presentations at the prestigious National Symposium on Healthcare Design. It includes a major introduction by Wayne Ruga, the guru of international healthcare facilities design, as well as chapters on medical offices, new technologies, healing environments, and acute, long-term, ambulatory, and pediatric facilities.

A Compendium of Neuropsychological Tests, Fourth Edition is one of the most well-established reference texts in neuropsychology. This newly-revised, updated, and expanded fourth edition provides a comprehensive overview of essential aspects of neuropsychological practice along with 100 test reviews of well-known neuropsychological tests for adults. The aim of the Compendium is to provide a comprehensive yet practical overview of the state of the field while also summarizing the evidence on the theoretical background, norms, reliability, and validity of commonly-used neuropsychological tests. Based on extensive review of the clinical and research literature in neuropsychology, neurology, and related disciplines, its comprehensive critical reviews of common neuropsychological tests and standardized scales include tests for premorbid estimation, dementia screening, IQ, attention, executive functioning, memory, language, visuospatial skills, sensory function, motor skills, performance validity, and symptom validity. Tables within each test review summarize important features of each test, highlight aspects of each normative dataset, and provide an overview of psychometric properties. This essential reference text also covers basic and advanced aspects of neuropsychological assessment with chapters on psychometric concepts and principles, reliability in neuropsychology, theoretical models of test validity, and an overview of critical concepts pertaining to performance and symptom validity testing and malingering. Of interest to neuropsychologists, clinical psychologists, educational psychologists, neurologists, and psychiatrists as well as trainees in these areas, this volume will aid practitioners in gaining a deeper understanding of fundamental assessment concepts in neuropsychology while also serving as an essential guidebook for selecting the right test for specific clinical situations and for helping clinicians make empirically-supported test interpretations.

Die haptische Wahrnehmung ist von elementarer Bedeutung fur die Planung, Steuerung und Ausfuhrung alltaglicher Handlungen. Diese dem Tastsinn zugeordnete Wahrnehmungsform findet immer groessere Beachtung. Mit aktuellen Ergebnissen aus interdisziplinarer Forschung und Praxis dokumentiert das Buch das zunehmende Interesse an diesem vielseitigen Forschungsgebiet. Nach einer erkenntnistheoretischen und historischen Einfuhrung widmen sich drei Kapitel neurophysiologischen Grundlagen sowie psychologischen und klinisch-neuropsychologischen Aspekten der haptischen Wahrnehmung. Vielfaltige Beispiele unter anderem aus der Automobil- und Lebensmittelindustrie sowie der Raumfahrt verdeutlichen den praktischen Nutzen der dargestellten Erkenntnisse. Das gut verstandliche Buch gewahrt Fachkundigen und Studenten, aber auch interessierten Laien einen Einblick in dieses faszinierende Wissensgebiet, das stets neue Herausforderungen entdeckt und innovative Loesungen prasentiert.

In thousands of communities across the United States, drinking water is contaminated with chemicals known as perfluoroalkyl and polyfluoroalkyl substances (PFAS). PFAS are used in a wide range of products, such as non-stick cookware, water and stain repellent fabrics, and fire-fighting foam, because they have properties that repel oil and water, reduce friction, and resist temperature changes. PFAS can leak into the environment where they are made, used, disposed of, or spilled. PFAS exposure has been linked to a number of adverse health effects including certain cancers, thyroid dysfunction, changes in cholesterol, and small reductions in birth weight. This report recommends that the Centers for Disease Control and Prevention (CDC) update its clinical guidance to advise clinicians to offer PFAS blood testing to patients who are likely to have a history of elevated exposure, such as those with occupational exposures or those who live in areas known to be contaminated. If testing reveals PFAS levels associated with an increased risk of adverse effects, patients should receive regular screenings and monitoring for these and other health impacts. Guidance on PFAS Exposure, Testing, and Clinical Follow-Up recommends that the CDC, Agency for Toxic Substances and Disease Registry (ATSDR), and public health departments support clinicians by creating educational materials on PFAS exposure, potential health effects, the limitations of testing, and the benefits and harms of testing. Table of Contents Front Matter Summary 1 Introduction 2 Principles for Decision Making Under Uncertainty 3 Potential Health Effects of PFAS 4 PFAS Exposure Reduction 5 PFAS Testing and Concentrations to Inform Clinical Care of Exposed Patients 6 Guidance for Clinicians on Exposure Determination, PFAS Testing, and Clinical Follow-Up 7 Revising ATSDR's PFAS Clinical Guidance 8 Implementing the Committee's Recommendations to Improve Public Health Appendix A: Committee Member, Staff, and Community Liaison Biographies Appendix B: Summary of the Committee's Town Halls Appendix C: Public Meeting Agendas Appendix D: Evidence Review: Methods and Approach Appendix E: White Paper: Review of the PFAS Personal Intervention Literature

IN